Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ALDH2_RAT
REST API REST API
Rattus norvegicus
ALDH2_RAT is differentially expressed in 72 experiments: 62 organism parts: hippocampus, frontal cortex, ... (60 more);, 5 disease states: normal, BDL 7 days, ... (3 more);, 12 cell types 13 compound treatments 2 age (months)s and 14 other conditions.
Synonyms Q91ZD7, Q8K3V8, Q6Q289, Q6Q288, Q6Q290
Orthologs Aldh2 (Mus musculus)   aldh2b (Danio rerio)   BX510999.1 (Danio rerio)   E1BT93_CHICK (Gallus gallus)   aldh2a (Danio rerio)   ALDH2 (Homo sapiens)   ALD5 (Saccharomyces cerevisiae)   ALD4 (Saccharomyces cerevisiae)   ALD6 (Saccharomyces cerevisiae)   CABZ01032488.1 (Danio rerio)   Aldh (Drosophila melanogaster)   RP11-162P23.2 (Homo sapiens)   aldh2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term oxidoreductase activity, metabolic process, mitochondrial matrix, identical protein binding, response to lipopolysaccharide, aldehyde dehydrogenase (NAD) activity, mitochondrion, response to nicotine, response to progesterone stimulus, response to testosterone stimulus, cellular response to fatty acid, liver development, cellular response to hormone stimulus, response to hyperoxia, oxidation-reduction process
InterPro Term Ald_DH/histidinol_DH, Ald_DH_CS, Aldehyde_DH_dom
UniProt Accession P11884, Q2QAI2, F1LN88
Search EB-eye ENSRNOG00000001344
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-19830, E-GEOD-2354, E-GEOD-20388, E-AFMX-7, E-GEOD-471, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-MEXP-31, E-GEOD-830, E-GEOD-2499, E-TABM-130, E-TABM-432 ... (5 experiments)

Factor Value U/D Experiments
spermatocyte
2
E-TABM-130, E-MEXP-31
Sertoli cell
1
2
1
E-TABM-432, E-TABM-130, E-MEXP-31
spermatogonia
1
E-MEXP-31
1
E-TABM-130
astrocyte
1
E-GEOD-2499
spermatogonium
1
E-TABM-432
6 more value(s).


Disease state

studied in E-GEOD-1872, E-GEOD-464, E-MEXP-2583

Factor Value U/D Experiments
moderate spinal cord injury
2
1
E-GEOD-464
breast carcinoma
1
E-GEOD-1872
Sham
1
E-MEXP-2583
normal
1
1
26
E-GEOD-1872, E-GEOD-464
BDL 7 days
1
E-MEXP-2583


Compound treatment

studied in E-MEXP-1169, E-GEOD-424, E-GEOD-2303, E-GEOD-6119, E-GEOD-4028, ... (7 experiments)

Factor Value U/D Experiments
valproic acid
1
E-GEOD-2303
forskolin
1
E-MEXP-1169
sulphated cholecystokinin-8
1
E-MEXP-1169
butyrate
1
E-GEOD-424
AICAR
1
E-GEOD-22647
dexamethasone + AICAR
1
E-GEOD-22647
7 more value(s).


age (months)

studied in E-GEOD-21681

Factor Value U/D Experiments
28
1
E-GEOD-21681
18
1
E-GEOD-21681


behavioral performance

studied in E-GEOD-21681

Factor Value U/D Experiments
not applicable
1
E-GEOD-21681


Clinical treatment
studied in E-GEOD-7002, E-GEOD-738

compound_treatment_design
studied in E-TABM-12

Day
studied in E-GEOD-20659

Developmental stage
studied in E-GEOD-4236, E-GEOD-13793, E-MEXP-570, E-GEOD-903, E-GEOD-20245 ... (5 experiments)

Genetic modification
studied in E-GEOD-6428

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-GEOD-6102, E-GEOD-1567

Material type
studied in E-GEOD-4192, E-MEXP-2527

Phenotype
studied in E-GEOD-7041

Protocol type
studied in E-GEOD-691, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-GEOD-7041, E-MTAB-322, E-TABM-457, E-GEOD-20388, E-GEOD-2116, ... (6 experiments)

Treatment
studied in E-GEOD-16981

Processing time: 0.635 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM